A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma

Table 4

Multivariate analyses for patients with ESCC.

	HR (95% CI)	value
Tumor length (cm)		0.603
≤3	1.000
>3	1.075 (0.818–1.412)
Vessel involvement		0.742
Negative	1.000
Positive	1.060 (0.747–1.505)
Perineural invasion		0.077
Negative	1.000
Positive	1.341 (0.968–1.857)
TNM stage		<0.001
I	1.000
II	1.586 (1.048–2.400)	0.029
III	2.220 (1.456–3.384)	<0.001
I stage		<0.001
I0	1.000
I1	1.543 (1.076–2.214)	0.018
I2	2.356 (1.602–3.466)	<0.001
I3	3.594 (2.363–5.467)	<0.001
CRP (mg/L)		0.493
≤10.0	1.000
>10.0	1.151 (0.770–1.719)
NLR		0.786
≤3.5	1.000
>3.5	1.050 (0.740–1.488)
PLR		0.065
≤150	1.000
>150	1.440 (0.978–2.121)